| December 2, 2014 |
|
|
| |
| Featured Content |
Developing Representative Sampling Plans for Development, Problem Solving, and Validation
The ability to define a scientifically justified and statistically sound sampling procedure is a fundamental skill in modern systematic drug development.
More |
New single-use bag family Flexsafe
Sartorius Stedim Biotech is introducing a brand-new, scalable range of single-use bags. Its completely new developed product family Flexsafe enables the implementation of single-use bioprocessing throughout all steps of drug manufacture, from process development to production, in upstream and downstream – all using just the one innovative polyethylene film.  Learn more
|
New Era for Generic Drugs
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
More |
|
| Top Stories |
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.
More |
Developing a Comprehensive Tool Kit for Microbial Identification
November 18, 2014
 Click here to Register Free. |
Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
Opdivo and investigational agent FPA008 will be tested in combination for their efficacy in boosting antitumor immune response.
More |
| Industry News |
AstraZeneca Expands Biologics Manufacturing in Maryland
The more than $200 million project will increase production capacity at the facility to support AstraZeneca's maturing pipeline.
More |
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
FDA will delay its decision regarding the new drug application for panobinostat.
More |
The Future of Continuous Downstream Processing
December 3, 2014
 Click here to Register Free. |
Lundbeck CEO Resigns Due to Code of Conduct Breach
Ulf Wiinberg has resigned as Lundbeck's CEO over unapproved acceptance of shares in a biotech company.
More |
IMS: Global Spending on Medicines to Rise 30% by 2018
Approximately 40% of total global growth will come from specialty medications, according to a new report from the IMS Institute for Healthcare Informatics.
More |
GSK Announces Shareholders Meeting to Discuss Novartis Deal
GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.
More |
Tufts’ New Figures on Drug-Development Costs Spark Debate
Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.
More |
Ireland: The Gateway to Biopharma's Future
Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.
More |
| Webcasts |
The Future of Continuous Downstream Processing
Wednesday, December 3, 2014, at 3 times - 3PM CST (Beijing); 11AM CET (Stockholm); 1PM EST (New York)
Sponsored by GE Healthcare |
| More Webcasts |
| |
©2012, Advanstar Communications, Inc.
485F US Highway 1 South, Suite 100
Iselin, NJ 08830
|
